PDF(Pubmed)
Abstract：
Percutaneous coronary intervention is the main strategy of revascularization and has been shown to improve outcomes in some patients with ST-segment elevation myocardial infarction (STEMI). However, multivessel disease (MVD), a common condition in these patients, is associated with worse clinical outcomes compared to single-vessel disease. Despite intervention being a standard treatment for coronary artery disease, optimal strategies and timings for patients with STEMI and MVD remain unclear. Numerous studies and meta-analyses have investigated this topic; however, many current conclusions are based on observational studies. Furthermore, clinical guidelines regarding the management of patients with STEMI and MVD contain conflicting recommendations. Therefore, we aimed to compile relevant studies and newly available evidence-based medicines to explore the most effective approach.
摘要：
经皮冠状动脉介入治疗是血运重建的主要策略，并已被证明可以改善某些ST段抬高型心肌梗死（STEMI）患者的预后。然而,多支血管疾病（MVD），这些患者的常见病，与单支血管疾病相比，临床结局较差。尽管干预是冠状动脉疾病的标准治疗方法，STEMI和MVD患者的最佳治疗策略和时机尚不清楚.许多研究和荟萃分析已经调查了这个话题；然而，目前的许多结论都是基于观察性研究。此外，关于STEMI和MVD患者管理的临床指南包含相互矛盾的建议.因此,我们旨在汇编相关研究和最新可用的循证药物，以探索最有效的方法。
